Chemoinformaics analysis of 2-TRANS-8-TRANS-PIPERAMIDE-C-9-2
| Molecular Weight | 327.424 | nRot | 7 |
| Heavy Atom Molecular Weight | 302.224 | nRig | 18 |
| Exact Molecular Weight | 327.183 | nRing | 3 |
| Solubility: LogS | -5.157 | nHRing | 2 |
| Solubility: LogP | 4.652 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 25 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 53.5758 |
| nHD | 0 | BPOL | 31.1302 |
| QED | 0.557 |
| Synth | 2.439 |
| Natural Product Likeliness | 0.394 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.982 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.773 |
| MDCK | 0.0000284 |
| BBB | 0.228 |
| PPB | 0.978521 |
| VDSS | 1.001 |
| FU | 0.0188073 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.464 |
| CYP2c19-inh | 0.912 |
| CYP2c19-sub | 0.376 |
| CYP2c9-inh | 0.556 |
| CYP2c9-sub | 0.792 |
| CYP2d6-inh | 0.937 |
| CYP2d6-sub | 0.911 |
| CYP3a4-inh | 0.953 |
| CYP3a4-sub | 0.194 |
| CL | 10.325 |
| T12 | 0.581 |
| hERG | 0.548 |
| Ames | 0.004 |
| ROA | 0.024 |
| SkinSen | 0.98 |
| Carcinogencity | 0.677 |
| EI | 0.354 |
| Respiratory | 0.969 |
| NR-Aromatase | 0.469 |
| Antiviral | Yes |
| Prediction | 0.731599 |